Skip to main content

Curet Myriam's Form 4 filing

Intuitive Surgical Inc (ISRG) · filed Nov 13, 2024

Accession no.
0001035267-24-000265
Filed
Nov 13, 2024
Trade date
Nov 12, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $7.22M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Curet MyriamCIK 0001632901Officer (EVP & Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 12, 2024Common StockMOption exerciseAcquired+2,257$177.99+$401,723.432,555Direct
Nov 12, 2024Common StockSSaleDisposed−2,257$535.96F2−$1,209,661.72298Direct
Nov 12, 2024Common StockMOption exerciseAcquired+5,000$182.83+$914,1505,298Direct
Nov 12, 2024Common StockSSaleDisposed−5,000$535.96F2−$2,679,800298Direct
Nov 12, 2024Common StockMOption exerciseAcquired+2,199$229.39+$504,428.612,497Direct
Nov 12, 2024Common StockSSaleDisposed−2,199$535.96F2−$1,178,576.04298Direct
Nov 12, 2024Common StockMOption exerciseAcquired+4,010$208.90+$837,6894,308Direct
Nov 12, 2024Common StockSSaleDisposed−4,010$535.96F2−$2,149,199.6298Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 12, 2024Common StockMOption exerciseDisposed−2,257$0.00$00Direct
Nov 12, 2024Common StockMOption exerciseDisposed−5,000$0.00$00Direct
Nov 12, 2024Common StockMOption exerciseDisposed−4,010$0.00$02,005Direct
Nov 12, 2024Common StockMOption exerciseDisposed−2,199$0.00$02,829Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 4 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)